Trial · NCT07893431
The Effect of Acupuncture on Passing Ureteral Stones
NCT07893431, Not applicable, Recruiting, Hitit University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Effect of Acupuncture on Passing Ureteral Stones. Trials, record NCT07893431. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07893431
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Effect of Acupuncture on Passing Ureteral Stones
- NCT number
- NCT07893431
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 40 participants, estimated
- Lead sponsor
- Hitit University
- Conditions
- Ureter Calculi
- Interventions
- medical expulsive therapy (tamsulosin), Acupuncture
- First posted
- 2026-10-26
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | stone passage rate within10 days | baseline to 10 days after initiation of treatment | the proportion of patientswho achieve spontaneous ureteral stone passage durıng the 10-day follow- up period. stone passage will be confirmed by patient report and, when clinially indicated, by imaging |
| Secondary | Time to ureteral stone expulsion | From treatment initiation through 10 days | Time from initiation of medical expulsive therapy to spontaneous ureteral stone expulsion, measured in days. |
| Secondary | Change in pain intensity assessed using the Visual Analog Scale (VAS) | Baseline to 10 days | Change in pain intensity assessed using the Visual Analog Scale (VAS), with scores ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable. Higher scores indicate greater pain intensity. Pain intensity will be assessed during the 10-day follow-up period. |
| Secondary | Analgesic use during follow-up | From treatment initiation through 10 day | The amount and frequency of analgesic medication use during the 10-day follow-up period will be compared between the treatment groups. |
| Secondary | Treatment-related adverse events | From treatment initiation through 10 days | The incidence and type of adverse events associated with medical expulsive therapy and acupuncture during the 10-day follow-up period. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07893431
GET https://conductscience.org/api/trials/v1/NCT07893431/registered